Revelation Biosciences's total assets for Q2 2025 were $5.40M, an increase of 35.89% from the previous quarter. REVB total liabilities were $1.57M for the fiscal quarter, a 44.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.